Suppr超能文献

组织蛋白酶D和纤溶酶原激活物抑制剂-1在人类头颈癌中的表达

Cathepsin D and PAI-1 expression in human head and neck cancer.

作者信息

Zeillinger R, Eder S, Schneeberger C, Ullrich R, Speiser P, Swoboda H

机构信息

Department of Obstetrics and Gynecology, University of Vienna, Austria.

出版信息

Anticancer Res. 1996 Jan-Feb;16(1):449-53.

PMID:8615652
Abstract

In order to determine possible overexpression of cathepsin D and PAI-1 (plasminogen activator inhibitor) in head and neck tumours, cytosols from 92 primary squamous cell carcinomas (SCC), 19 lymph node metastases and 24 adjacent normal tissue samples were examined. For both cathepsin D and PAI-1, significantly elevated concentrations in SCC compared to normal tissue were found, even in pairwise comparison. Moreover, significantly higher cathepsin D and PAI-1 concentration in lymph node metastases than in corresponding normal tissue were also present. The conclusion was drawn that cathepsin D and PAI-1 may play a specific role in the biology of head and neck SCC.

摘要

为了确定组织蛋白酶D和PAI-1(纤溶酶原激活物抑制剂)在头颈部肿瘤中是否可能过度表达,研究人员检测了92例原发性鳞状细胞癌(SCC)、19例淋巴结转移灶以及24例相邻正常组织样本的胞质溶胶。对于组织蛋白酶D和PAI-1,与正常组织相比,即使在两两比较中,SCC中的浓度也显著升高。此外,淋巴结转移灶中的组织蛋白酶D和PAI-1浓度也明显高于相应的正常组织。由此得出结论,组织蛋白酶D和PAI-1可能在头颈部SCC的生物学过程中发挥特定作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验